94 related articles for article (PubMed ID: 3602910)
41. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
[TBL] [Abstract][Full Text] [Related]
42. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
Traissac L; Roche JC
Rev Laryngol Otol Rhinol (Bord); 1979; 100(1-2):151-61. PubMed ID: 379941
[No Abstract] [Full Text] [Related]
43. Binding of the anti-inflammatory drug niflumic acid to bovine serum albumin.
Kelmer-Bracht AM; Ishii-Iwamoto EL; Bracht A
Braz J Med Biol Res; 1990; 23(9):789-94. PubMed ID: 2101318
[TBL] [Abstract][Full Text] [Related]
44. Clinical evaluation of niflumic acid gel in the treatment of uncomplicated ankle sprains.
Dreiser RE; Charlot J; Lopez A; Ditisheim A
Curr Med Res Opin; 1990; 12(2):93-9. PubMed ID: 2202553
[TBL] [Abstract][Full Text] [Related]
45. [Niflumic acid].
Danysz A
Reumatologia; 1975; 13(3):227-32. PubMed ID: 1101331
[No Abstract] [Full Text] [Related]
46. [Agranulocytosis caused by niflumic acid (Infaryl)].
Kallenberg CG; Roenhorst HW
Ned Tijdschr Geneeskd; 1979 Jul; 123(28):1207-8. PubMed ID: 471094
[No Abstract] [Full Text] [Related]
47. [Drug concentrations in blood, synovial fluid, synovial membrane, periarticular bone, muscle and adipose tissue in patients with rheumatoid polyarthritis receiving a single intramuscular injection of ketoprofen or acetylsalicylic acid (3 hours after the injection)].
Köhler G; Mohing W; Lutz D; Morand J
Sem Hop; 1983 Dec; 59(46):3210-3. PubMed ID: 6318343
[TBL] [Abstract][Full Text] [Related]
48. Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat.
Carini M; Aldini G; Orioli M; Piccoli A; Rossoni G; Maffei Facino R
Life Sci; 2004 May; 74(26):3291-305. PubMed ID: 15094329
[TBL] [Abstract][Full Text] [Related]
49. Direct determination of niflumic acid in a pharmaceutical gel by ATR/FTIR spectroscopy and PLS calibration.
Boyer C; Brégère B; Crouchet S; Gaudin K; Dubost JP
J Pharm Biomed Anal; 2006 Feb; 40(2):433-7. PubMed ID: 16122895
[TBL] [Abstract][Full Text] [Related]
50. Niflumic acid and mucocutaneous reactions.
Menniti-Ippolito F; Traversa G; Da Cas R; Leone R; Caputi A
Pediatrics; 2006 Jan; 117(1):253-4; author reply 254-5. PubMed ID: 16396893
[No Abstract] [Full Text] [Related]
51. Quantitation of niflumic acid in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection and its application to a bioequivalence study of talniflumate tablets.
Lee HW; Won KJ; Cho SH; Ha YH; Park WS; Yim HT; Baek M; Rew JH; Yoon SH; Yim SV; Chung JH; Lee KT
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):215-20. PubMed ID: 15921965
[TBL] [Abstract][Full Text] [Related]
52. Dermatomyositis-like syndrome induced by nonsteroidal anti-inflammatory agents.
Grob JJ; Collet AM; Bonerandi JJ
Dermatologica; 1989; 178(1):58-9. PubMed ID: 2917682
[TBL] [Abstract][Full Text] [Related]
53. Thermodynamic properties of flufenamic and niflumic acids--specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution.
Perlovich GL; Surov AO; Bauer-Brandl A
J Pharm Biomed Anal; 2007 Nov; 45(4):679-87. PubMed ID: 17336023
[TBL] [Abstract][Full Text] [Related]
54. Experiences with the combined use of Mydocalm + Donalgin in the treatment of patients suffering from lumboischialgia.
Kumin M; Saál M; Ambrózy G
Ther Hung; 1984; 32(1):26-8. PubMed ID: 6242725
[No Abstract] [Full Text] [Related]
55. Niflumic acid-induced skeletal fluorosis: iatrogenic disease or therapeutic perspective for osteoporosis?
Meunier PJ; Courpron P; Smoller JS; Briancon D
Clin Orthop Relat Res; 1980 May; (148):304-9. PubMed ID: 7379406
[TBL] [Abstract][Full Text] [Related]
56. An HPLC method for the determination of flunixin in bovine plasma and milk.
Neff-Davis CA; Bosch K
J Vet Pharmacol Ther; 1985 Sep; 8(3):331-4. PubMed ID: 3877175
[No Abstract] [Full Text] [Related]
57. [The beta-morpholino ethyl ester of niflumic acid in the treatment of orchi-epididymitis].
Mazeman E; Biserte J
Lille Med; 1980 Nov; 25(9):541-4. PubMed ID: 7453494
[No Abstract] [Full Text] [Related]
58. [Multicenter study of the anti-inflammatory and analgesic effects of niflumic acid with antibiotics, used preoperatively in dentistry].
Missika P; Ouvrard ; Coudert ; De Mello ; Duran ; Durivaux ; Gass ; Hirigoyen ; Jeandot ; Terrestri
Inf Dent; 1990 May; 72(22):1907-10. PubMed ID: 2202676
[No Abstract] [Full Text] [Related]
59. [Urinary toxicological screening: analytical interference between niflumic acid and cannabis].
Boucher A; Vilette P; Crassard N; Bernard N; Descotes J
Arch Pediatr; 2009 Nov; 16(11):1457-60. PubMed ID: 19716686
[TBL] [Abstract][Full Text] [Related]
60. Clinical examination of the synergistic effect of niflumic acid and tolperisone in genicular arthritis.
Dömötör E
Ther Hung; 1979; 27(3):129-33. PubMed ID: 531773
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
